A Phase 2 Efficacy and Safety Study of Niraparib in Men with Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
To establish safety and efficacy of Niraparib in patients with targeted DNA- repair anomalies
This Study is
No Longer Enrolling
Adult
II - Research Studies that gather preliminary data on whether a drug works in people who have a certain condition/disease (that is, the drug's effectiveness). For example, participants receiving the drug may be compared to similar participants receiving a different treatment, usually an inactive substance (called a placebo) or a different drug. Safety continues to be evaluated, and short-term adverse events are studied.
Treatment
National
University of Colorado Hospital
Protocol Number: 16-1470
More information available at ClinicalTrials.gov: NCT02854436
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers